2019 Policy Summit

November 4-6, 2019

Revisit ASGCT's First Public Policy Summit

After hosting an invite-only summit in 2019, ASGCT opened the doors to Policy Summit registration to the public with keynote addresses from NIH Director Francis Collins, M.D., Ph.D. and WHO Advisory Committee Co-Chair Margaret Hamburg, M.D.

2019 Policy Summit Content

Global Regulatory Issues in Gene Therapy Development

November 4: Explore solutions to challenges experienced both by global regulators and by sponsors developing gene therapies across established and emerging markets.

Perspectives on Payment Policies for Gene Therapies

November 5: Address the status of legislative and regulatory solutions to the primary challenges in paying for gene therapies for different payer types, as well as the current state of Medicaid reimbursement policies for these therapies.

Ethical, Societal, and Policy Issues in Germline Gene Editing

November 6: Stakeholders discuss considerations surrounding germline gene editing, including current legal status for clinical research; recent proposals to limit clinical applications; and potential mechanisms necessary to achieve societal consensus.


Policy Summit

Sept. 18-19 | Washington, DC

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.